drugset / Trial / NCT00999752

Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension

NCT00999752

Completed 40 enrolled InVasc Therapeutics, Inc.
RandomizedSingle-groupOpen-labelDiagnostic

Summary

The main purpose of this study is to evaluate the effects of Nebivolol and Hydrochlorothiazide on blood pressure in African Americans with high blood pressure.

Timeline

Start
2009-10
Primary completion
2010-02
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 25 mg
Comparator Nebivolol Other / unclassified 10 mg

Indications